Jenski L J, Hong R
J Immunol. 1985 Aug;135(2):947-53.
Athymic (nude) mice were transplanted with cultured thymic fragments from syngeneic, allogeneic, and partially allogeneic (recombinant) mice. Lymphocyte proliferation and cytotoxicity in vitro were measured to assess immunologic reconstitution. Transplanted nude mice were immunocompetent whether donor and recipient were disparate for class I, class II, or both H-2 gene types. Furthermore, allotolerance for thymic H-2 class I antigens was achieved independently of class II antigen allotolerance. Class I antigen tolerance was not broken during lymphocyte responses to unrelated alloantigens, ruling out insufficient help as the tolerance mechanism. Splenocytes, isolated from nude mice transplanted with fully allogeneic or syngeneic thymic fragments and stimulated in vitro with trinitrophenyl-modified cells, displayed H-2-restricted, hapten-specific cytotoxicity. Cytotoxic cells from allotolerant mice were restricted to either host or thymic H-2 antigens, depending on the stimulating cell haplotype. Response levels for thymic and host trinitrophenyl-modified cells were comparable. We have shown that allogeneic thymic epithelium transplanted into adult nude mice can induce allotolerance to class I and II H-2 antigens equally, and permits T lymphocyte interaction with cells bearing thymic donor or host H-2 antigens. Our results are consistent with a model wherein T lymphocyte self-receptors retain their genomic repertoire but can be selectively mutated or expanded by appropriate H-2 antigen presentation by the thymus.
将同基因、异基因和部分异基因(重组)小鼠培养的胸腺片段移植到无胸腺(裸)小鼠体内。检测体外淋巴细胞增殖和细胞毒性以评估免疫重建情况。无论供体和受体在I类、II类或两种H-2基因类型上是否不同,移植后的裸小鼠都具有免疫能力。此外,对胸腺H-2 I类抗原的同种耐受是独立于II类抗原同种耐受而实现的。在淋巴细胞对无关同种异体抗原的反应过程中,I类抗原耐受未被打破,排除了辅助不足作为耐受机制的可能性。从移植了完全异基因或同基因胸腺片段的裸小鼠中分离出脾细胞,并在体外用三硝基苯基修饰的细胞刺激,这些脾细胞表现出H-2限制的、半抗原特异性的细胞毒性。同种耐受小鼠的细胞毒性细胞根据刺激细胞的单倍型,局限于宿主或胸腺H-2抗原。对胸腺和宿主三硝基苯基修饰细胞的反应水平相当。我们已经表明,移植到成年裸小鼠体内的异基因胸腺上皮可以同等地诱导对I类和II类H-2抗原的同种耐受,并允许T淋巴细胞与携带胸腺供体或宿主H-2抗原的细胞相互作用。我们的结果与一个模型一致,在该模型中,T淋巴细胞自身受体保留其基因组库,但可以通过胸腺适当的H-2抗原呈递而被选择性地突变或扩增。